Add Yahoo as a preferred source to see more of our stories on Google. Lenacapavir is now approved to prevent HIV infection as well as to treat certain infections. - Gilead Sciences Inc. A drug ...

Human immunodeficiency virus (HIV) affects a person’s immune system. People with HIV can take medication to prevent it from progressing to acquired immunodeficiency syndrome (AIDS). However, HIV ...

Add Yahoo as a preferred source to see more of our stories on Google. The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV. The drug, ...

A groundbreaking annual injection designed to protect against Human Immunodeficiency Virus (HIV) has successfully passed an important early safety trial. Researchers have shared that the drug ...

The department has identified specific demographics for the initial phase of the rollout to ensure the most vulnerable ...

On June 5, South Africa is about to begin one of its most important HIV prevention drives in decades. The country will start to roll out an HIV prevention injection that has to be taken only twice a ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A brand new drug might be more effective at preventing HIV than current ...

The Food and Drug Administration approved Gilead's twice-yearly antiviral drug for preventing HIV. The company and some experts say it is a milestone that could help bring the world closer to ending ...

Doctors at DAP Health have begun administering a new twice-a-year injectable HIV prevention medication, which was approved by the Food and Drug Administration in June. Gilead's drug lenacapavir ...

In the long battle to create an effective HIV vaccine, scientists have made a major leap forward. A new study shows that a series of vaccines can coax the immune system to produce powerful antibodies ...

Many vaccines work because viruses stay relatively stable. HIV behaves differently; it mutates rapidly, creates many variants ...

The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV. The drug, called Yeztugo from company Gilead Sciences, was approved Wednesday based ...